curriculum vitae (.doc).doc.doc.doc
TRANSCRIPT
CURRICULUM VITAE
DEBABRATA MUKHERJEE, MD, MS, FACC
Business Address: Gill Foundation Professor of Interventional Cardiology
Associate Professor of Internal Medicine
Director of Cardiac Catheterization Laboratories
Director of Peripheral Intervention Program
Gill Heart Institute, Division of Cardiovascular Medicine
University of Kentucky
900 S. Limestone Street, 326B Wethington Building
Lexington, KY 40536-0200
Tel: 859-323-5630
Fax: 859-323-6475
Email: [email protected]
Home Address: 4390 Clearwater way
Lexington, KY 40515
Tel: 859 271 8472
Email: [email protected]
Education:
1988 MD, Government Medical College, Nagpur (India)
1990 ECFMG Certified
1990 FLEX
1990 Medical Council of Canada, Evaluating Examination
2001-03 Masters in Clinical Research (University of Michigan)
Professional Experience:
01/89 - 12/92 Fellow in Molecular Cardiology, The Cleveland Clinic
Foundation, Cleveland, Ohio.
01/93 - 02/96 Resident in Internal Medicine, The Cleveland Clinic Foundation,
Cleveland, Ohio.
06/96 – 06/99 Fellow in Clinical Cardiology, The Cleveland Clinic Foundation,
Cleveland, Ohio.
07/99 – 06/00 Fellow in Interventional Cardiology and Peripheral Vascular
Interventions, The Cleveland Clinic Foundation
07/00 – 06/01 Chief Interventional Cardiology Fellow, The Cleveland Clinic
Foundation
07/01 –09/04 Director of Peripheral Vascular Interventions for Cardiology,
Assistant Professor Division of Cardiology, University of
Michigan
10/04 – present Gill Foundation Professor of Interventional Cardiology, Director
of Peripheral Vascular Interventions
07/06-present Director Cardiac Catheterization Laboratories, University of
Kentucky
Grant Support:
2
American Heart Association Grant-in-Aid, 1999-2001 (Northeast
Ohio chapter)
American College of Cardiology Career Development Award,
2002-2003
Cleveland Clinic Foundation, PPAR agonists for the prevention of
adverse events following percutaneous coronary revascularization,
2002-2003, [Role – Local PI]
Astra Zeneca, A 104-Week, Open-Label, Multi-Center, Phase IIIb
Study Evaluating The Effect Of Treatment With Rosuvastatin 40
mg On Atherosclerotic Disease As Measured By Intravascular
Ultrasound And Quantitative Coronary Angiography In Subjects
Undergoing Coronary Angiography Who Have Coronary Artery
Disease, 2003-2004, [Role – Local PI]
PFIZER, A Phase 3, Multi-Center, Double-Blind, Randomized,
Parallel Group, Coronary Artery Intravascular Ultrasound
Evaluation of the Anti-Atherosclerotic Efficacy, Safety and
Tolerability of Fixed Combination CP-529,414/Atorvastatin
Administered Orally, Once Daily (QD) for 24 Months, Compared
with Atorvastatin alone, in subjects with Angiographically
Documented Coronary Heart Disease, 2004-2006, [Role – Local
PI]
Sanofi-Aventis, A randomized dose ranging Study of
Hexasaccharide including active control, in patients with Unstable
Angina or Non ST-segment Elevation Myocardial Infarction
scheduled to undergo Percutaneous Coronary Intervention
(SHINE), 2005 -2007, [Role – Local PI]
3
Conor Medsystems, COSTAR II trial (CObalt chromium STent
with Antiproliferative for Restenosis), 2005-2007, [Role – Local
PI]
NIH, GCRC Grant # M01 RR02602, Study # G5-0262 , Effect of
Mineralocorticoid Receptor Antagonism on Thrombosis,
Inflammation, and Oxidative Stress in Patients with Acute
Coronary Syndromes, 2005-2006, [Role – Co Principal
Investigator and Mentor]
Abbott Vascular CAPTURE – 2, Post-market surveillance to
document clinical outcomes involving the RX ACCULINK
Carotid Stent System and RX ACCUNET Embolic Protection
System (EPS) [Role – Local PI]
Licensure:
Ohio Medical license
Michigan Medical license
Kentucky Medical license
Board Certification:
1996 Internal Medicine
1999 Cardiovascular Diseases
2000 Interventional Cardiology
2005 Recertification in Internal Medicine
2005 Recertification in Cardiovascular Disease
Awards and Honors:
4
1979-86 Recipient of State Scholarship
1986 Recognition Award, Indian Council of Medical Research
1988 LN Jaiswal Gold Medal - First in University (MD)
1988 Sadiq Vali Gold Medal - First in Pediatrics (MD)
1988 DB Jaiswal Gold Medal - First in Medicine (MD)
1990 American Heart Association Research Fellowship
1990 Robert C Tarazi Fellowship Award for excellence in
cardiovascular research
1991 American Heart Association Research Fellowship
1997 Bristol – Myers Squibb Travel Award, American Heart
Association 70th Scientific Sessions
1998 Affiliate Travel Award, American college of Cardiology 47th
Scientific Sessions
1999 Young Investigator Award Finalist, American College of
cardiology 48th Scientific Sessions
1999 Astra-Zeneca Young Investigator Award Finalist
1999 First prize for Abstract, 9th Annual sessions of the Ohio chapter of
the American College of Cardiology
2000 Astra-Zeneca Young Investigator Award Finalist
2000 First prize for Abstract, 10th Annual sessions of the Ohio chapter of
the American College of Cardiology
2001 Joseph Cash Memorial Award for excellence in Health outcome
research
2002-03 American College of Cardiology/William F. Keating Career
Development Award for Hypertension and Peripheral Vascular
Disease
2003-2004 University of Michigan Cardiovascular Center McKay Research
Grant for Peripheral Arterial Disease
2006 Who’s Who in America
2007-08 Best Doctors in America
5
Memberships:
2005 – presentFellow of the Society for Vascular Medicine and Biology
2003 - present Fellow of the American College of Cardiology
1996 - present American College of Cardiology
1993 - present American College of Physicians
1993 - present American Medical Association
1991 - present International Federation for the Advancement of Genetic
Engineering and Biotechnology
1990 - present American Heart Association
1989 - present American Association for the Advancement of Science
1984 -1985 Indian Council of Medical Research
Teaching Activities:
2001 – 2002 Mentor, Undergraduate Research Opportunity Program (UROP)
2001 – 2004 Fellow supervisor, Cardiac Catheterization Laboratory at UMHS
2001 – 2004 Staff Attending, Cardiology Consult Service at UMHS
2001 – 2003 Medical Student Research Mentor
2004 – presentFellow supervisor, Cardiac Catheterization Laboratory at UK
2001 – presentStaff Attending, Cardiology Consult Service at UK
2005-present K30 Research Mentor for Dr Rohit Bhatheja
Professional Activities:
1997 - 1998 Clinical Events Committee, EPISTENT study
1998 – 1999 Clinical Events Committee, SYMPHONY study
2000 – 2001 Clinical Events Committee, TARGET study
2004 – 2005 Data Safety Monitoring Committee, STEEPLE Study
2004- 2005 Steering Committee, TENACITY study
2006– 2008 Steering Committee, MR PCI Study
6
2006– present Data Safety Monitoring Committee, PRECISION Study
2006– present Steering Committee, MIDAS Study
2001–present Manuscript reviewer:
American Heart Journal
American Journal of Cardiology
American Journal of Hypertension
American Journal of Medicine
Atherosclerosis
Arteriosclerosis, Thrombosis and Vascular Biology
Circulation
Cleveland Clinic Journal of Medicine
European Heart Journal
Heart
Journal of the American College of Cardiology
JAMA
Joint Commission Journal on Quality and Patient Safety
Lancet
Nature Clinical Practice Cardiovascular Medicine
Stroke
The Journal of Rheumatology
Vascular Medicine
CMAJ
2003 National Heart Lung and Blood Institute Special Emphasis Panel
(Ancillary Pharmacogenetic Studies)
2003 Canadian Institute of Health Research (External reviewer)
2002–2006 Assistant Editor, ACC Current Journal Review
2006-present Associate Editor, ACC Cardiosource Review Journal
2003- present Editorial Board, Vascular Disease Prevention
2004-present International Editor, The Reviews
2005- present Editorial Board, International Journal of Angiology
7
2005- present Editorial Board, American Heart Journal
2006- present Editorial Board, Indian Heart Journal
2006- present Editorial Board, Recent Patents on Cardiovascular Drug Discovery
2006- present Editorial Board, American Journal of Managed Care
2007-present Editorial Board, The Open Health Services and Policy Journal
2005 -2008 Member, Cardiac Catheterization and Intervention Committee,
American College of Cardiology
2006-2009 American College of Cardiology i2 Summit Advisory Work Group
2007 -2010 Member, American College of Cardiology Task Force on
Clinical Expert Consensus Documents
2007 -2010 Heart Education Advisory and Research Team, (HEART),
Commonwealth of Kentucky
2008 – 2013 Editor–in-Chief, Cardiology Reviews
2008 - 2011 Member, Cardiac Catheterization and Intervention Committee,
American College of Cardiology
Publications:
1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of
myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 67: 1474-80, 1990.
2. Mukherjee D and Sen S. Alteration of collagen phenotypes in ischemic
cardiomyopathy. J Clin Inv 88: 1141- 46, 1991.
3. Mukherjee D, McTiernan CF and Sen S. Myotrophin induces early response genes
and causes enhanced cardiac gene expression. Hypertension 21: 142 - 48, 1993.
4. Mukherjee D and Sen S. Alteration of collagen phenotypes in hypertensive
hypertrophy: Role of blood pressure. J Mol Cell Cardiol 25: 185 - 96, 1993.
8
5. Mukherjee D, Lange P, Sferry C, Joseph J and Mehta A. Dyspnea, cough and chest
pain in a 35-year-old woman. Chest 107: 1460 - 62, 1995.
6. Sil P, Mukherjee D and Sen S. Quantification of myotrophin from spontaneously
hypertensive and normal rat hearts. Circ Res 76(6): 1020 - 27, 1995.
7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ.
Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following
intracoronary stenting. J Am Coll Cardiol 32(5): 1366-70, 1998.
8. Mukherjee D, Bhatt DL, Roe MT, Patel V and Ellis SG. Direct Myocardial
Revascularization and Angiogenesis - How Many Patients Might be Eligible? Am J
Cardiol 84(5): 598-600, 1999.
9. Ellis SG, Cura FA and Mukherjee D. Prospects for therapeutic angiogenesis and
myogenesis in patients with advanced coronary disease. J Invasive Cardiol 11(10): 615-
17, 1999.
10. Mukherjee D and Moliterno DJ. Prompt Use of Reteplase (RetavaseTM) For Acute
Myocardial Infarction: Facilitating Percutaneous Coronary Intervention and Early
Hospital Discharge. J Invasive Cardiol [Clinical Case Update] Vol 2(2); March 2000
11. Bishay ES, McCarthy PM, Cosgrove DM, Hoercher KJ, Smedira NG, Mukherjee D,
White J, and Blackstone EH. Mitral valve surgery in patients with severe left ventricular
dysfunction. Euro J CardioThoracic Surg; 17:3:213-221, March 2000
12. Mukherjee D and Moliterno DJ. Applications of anti-platelet monitoring in the
catheterization laboratory. J Thrombosis and Thrombolysis 9(3): 293-301, April 2000
9
13. Mukherjee D and Moliterno DJ. Achieving tissue-level perfusion in the setting of
Acute Myocardial Infarction. Am J Cardiol 85 (8A): 39C – 46C, April 2000
14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten
fold augmentation of endothelial uptake of vascular endothelial growth factor with
ultrasound after systemic administration.. J Am Coll Cardiol 35(6): 1678-86, May 2000.
15. Mukherjee D and Ellis SG. Use of rescue angioplasty for failed thrombolysis.
Cleveland Clinic J of Medicine 67(5): 341–352, May 2000
16. Mukherjee D, Nader S, Olano A, Garcia M, and Griffin BP. Improvement in right
ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid
regurgitation. J Am Soc Echo 13(7):650-654, July 2000
17. Mukherjee D and Ellis SG. New options for untreatable coronary artery disease:
Angiogenesis and Laser revascularization. Cleveland Clinic J of Medicine 67(8): 577 –
583, August 2000.
18. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R,
Whitlow PL, Franco I, and Ellis SG. Unexpected Mortality reduction with abciximab for
in-stent restenosis. J Invasive Cardiology 12(11): 540-544, Nov 2000
19. Mukherjee D and Yadav SJ. Carotid and cerebrovascular disease. Cardiology in
Review 8 (6): 322–332, Nov 2000
20. Mukherjee D and Moliterno DJ. Monitoring antiplatelet therapy: What is the best
method? Clinical Pharmacokinetics, 39(6): 445-458, Dec 2000
21. Moliterno DJ and Mukherjee D. Applications of monitoring platelet glycoprotein
IIb/IIIa antagonism and low-molecular-weight heparins in cardiovascular medicine. Am
Heart J, 140 (6 Pt 2):S136-S142, Dec 2000
10
22. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting in high-risk patients.
Carotid Intervention 3 (1), 13-15, Jan 2001
23. Mukherjee D, Chew DP, Robbins M, Yadav J, Raymond RE, and Moliterno DJ.
Clinical Application of Procedural Platelet Monitoring During Percutaneous Coronary
Intervention Among Patients at Increased bleeding Risk. J Thrombosis and Thrombolysis
11, 143 – 146, April 2001
24. Mukherjee D, Roffi M, Kapadia S, Bhatt DL, Bajzer C, Ziada KM, Kalahasti V,
Hughes K, and Yadav JS Percutaneous Intervention for symptomatic vertebral artery
stenosis using coronary stents. J Inv Cardiology 13, 363-366, May 2001
25. Mukherjee D and Yadav SJ. Effect of Contralateral Occlusion on long-term Efficacy
of Endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke
32(6):1443-1448 June 2001
26. Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V and Ellis SG. Clinical
Outcome of a Cohort of Patients Eligible for Therapeutic Angiogenesis or
Transmyocardial Revascularization Am Heart J 142: 72-74, July 2001
27. Mukherjee D and Yadav SJ. Update on peripheral vascular diseases: From smoking
cessation to stenting. Cleveland Clinic J of Medicine 68: 723-734, August 2001
28. Mukherjee D, Nissen SE, Topol EJ. Risk of Cardiovascular Events Associated With
selective COX-2 Inhibitors. JAMA 286: 954-959, August 2001
29. Chew DP, Bhatt DL, Robbins M, Mukherjee D, Roffi M, Schneider JP, Topol EJ,
and Ellis SG. Effect of clopidogrel added to aspirin before percutaneous coronary
intervention on the risk associated with C-reactive protein. Am J Cardiol 88(6): 672-674,
September 2001
11
30. Mukherjee D and Eagle KA. Increase in Peripheral Interventional Procedures by
Cardiologists – Are Patients being Served? Effective Clin Practice 4: 221-222, October
2001
31. Mukherjee D, Nissen SE, Topol EJ. COX-2 inhibitors and cardiovascular risk. We
defend our data and suggest caution. Cleveland Clinic J of Medicine 68: 963-964,
November 2001
32. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer
C, Navarro F and Yadav JS. Renal artery end diastolic velocity and
renal artery resistance index as predictors of outcome after renal
stenting. Am J Cardiol 88(9): 1064-66, Nov 2001
33. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, and
Yadav JS. Self-expanding stents for carotid intervention: Comparison of Nitinol versus
stainless steel stents. J Inv Cardiol 13(11):732-735, Nov 2001
34. Mukherjee D. Therapeutic angiogenesis in the treatment of coronary artery disease.
Cardiology Update 1(1): 100-106, Dec 2001
35. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M,
Topol EJ and Yadav JS. Dual Antiplatelet Therapy with Clopidogrel and Aspirin after
Carotid Artery Stenting. J Inv Cardiol 13: 767-771, 2001
36. Mukherjee D, Nissen SE, Topol EJ. Cardiovascular Events and COX-2 Inhibitors.
JAMA. 286:2808-2813, Dec 2001
37. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW,
Moliterno DJ, Cakliff RM, White HD, Kleiman NS, Theroux P, Topol EJ. Platelet
12
Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients with Non-ST-
Segment Elevation Acute Coronary Syndromes. Circulation 104:2767-71, Dec 2001
38. Mukherjee D, Roffi M, Bajzer C, and Yadav J. Endovascular Treatment of Carotid
Artery Aneurysms with Covered Stents. Circulation 104(24):2995, Dec 2001
39. Roffi M, Robbins MA, Mukherjee D, Bhatt DL, Bajzer C, Yadav JS. Carotid
stenting with emboli protection device. Images in Cardiovascular Medicine.
Kardiovaskulare Medizin 4:347-8, Dec 2001
40. Mukherjee D and Yadav J. Endovascular therapy for symptomatic vertebral artery
stenosis. Carotid Intervention 3 (3), 13-15, Jan 2002
41. Mukherjee D. Selective Cox-2 Inhibitors and Potential Risk of Cardiovascular
Events. Biochem Pharmacol 63 (5), 817-821, March 2002
42. Mukherjee D, Roffi M, and Yadav J. Endovascular Treatment of Carotid Artery
Aneurysms with stent grafts. J Invasive Cardiol 14: 269-72, May 2002
43. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases. Prog
Cardiovasc Dis 44 (6), 479 – 498, June 2002
44. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C,
Hamm CV, Robbins MA, Kleinman NS, Théroux P, White HD, Topol EJ. Platelet
Glycoprotein IIb/IIa Inhibition in Acute Coronary Syndromes: Gradient of Benefit
Related to the Revascularization Strategy. European Heart Journal 23: 1441–1448,
September 2002
45. Mukherjee D and Eagle KA. Coronary revascularization prior to elective vascular
surgery: Does it reduce cardiac risk? J Vascular Surgery 36:644-645, September 2002
13
46. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, and
Eagle KA. Missed Opportunities to Treat Atherosclerosis in Patients Undergoing
Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral
Vascular Disease Quality Improvement Initiative (PVD-QI2) Circulation 106:1909-
1912; October 2002
47. Mukherjee D and Topol EJ. The Role of Low-Molecular Weight Heparin in
Cardiovascular Diseases. Prog Cardiovasc Dis 45(2): 139 –156, October 2002
48. Mukherjee D and Yadav J. Carotid artery intimal-medial thickness: indicator of
atherosclerotic burden and response to risk factor modification. Am Heart J 144; 753-
759, November 2002
49. Mukherjee D and Eagle KA. A common sense approach to peri-operative
evaluation. Am Fam Physician 66:1824-26, November 2002.
50. Mukherjee D and Yadav J. Percutaneous Treatment for Carotid Stenosis. Cardiology
Clinics 20(4): 589-97, November 2002
51. Chan AW, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray BH, Baizer CT, and
Yadav JS. Percutaneous treatment for pacemaker-associated superior vena cava
syndrome. Pacing Clin Electrophysiol 25(11):1628-33, November 2002
52. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V,
Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Outcome of Acute ST-
segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery Bypass
Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet
Glycoprotein IIb/IIIa Inhibition. Am J Cardiol 90:1198–1203, December 2002
53. Mukherjee D, Nissen SE, and Topol EJ. Lack of cardioprotective effect of
naproxen. Archives of Internal Medicine 162(22): 2637 December 2002
14
54. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM,
Brennan DM, Ellis SG, Topol EJ. Lack of Benefit from Intravenous Platelet
Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous
Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized
Clinical Trials. Circulation 106: 3063 –3067, December 2002
55. Tamirisa K and Mukherjee D. Gene therapy in cardiovascular diseases. Curr Gene
Therapy 2 ( 4): 427-435, December 2002
56. Mukherjee D and Eagle KA. Cardiac risk in noncardiac surgery. Minerva
Cardioangiologica 50(6):607-19, December 2002
57. Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav J, Pieper KS,
Gallup D, Dyke C, Roe MT, Berdan L, Lauer M, Mänttäri M, White HD, Califf RC, and
Topol EJ. The promise of combined Low-Molecular-Weight Heparin and platelet
Glycoprotein IIb/IIIa Inhibition--Results from PARAGON B. Am Heart J 144: 995 –
1002, December 2002
58. Mukherjee D, and Topol EJ. COX-2: Where are we in 2003? Arthritis Research
5(1): 8 – 11, January 2003
59. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL,
Ghaffari S, and Yadav J. Carotid brachytherapy for in-stent restenosis. Cathet
Cardiovasc Intervent 58(1): 86-92, January 2003
60. Cura FA, Kapadia SR, L'Allier PL, Ziada KM, Mukherjee D, Wolski KE, Yadav JS,
Brener SJ, Whitlow PL, Topol EJ and Ellis SG. Effect of uncoated stenting versus
balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on One-
Year Event-Free survival, Am J Cardiol 91(5): 587-590, March 2003
15
61. Cho L, Roffi M, Mukherjee D, Bhatt DL, Bajzer C and Yadav JS. Superficial
femoral artery occlusion: Nitinol stents achieve better flow and reduces the need for
medications than balloon angioplasty alone J Inv Cardiology 15(4): 198-200, April 2003
62. Nallamothu BK Chetcuti S, Mukherjee D, Grossman PM, Kline-Rogers E, Werns S,
Bates ER; Moscucci M. The Impact of Troponin-I Elevation After Percutaneous
Coronary Intervention on Long-Term Survival. Am J Cardiol 91(10):1272-1274, May
2003.
63. Mukherjee D and Eagle KA. Predictors of Missed Opportunities for Reperfusion in
ST-segment-elevation Myocardial Infarction in the Global Registry of Acute Coronary
Events (GRACE). Cardiovascular Reviews & Reports 24:249-250, May 2003
64. Mukherjee D and Eagle KA. What's new in the treatment of acute coronary
syndromes? Emergency Medicine 35(5); 34 – 48, May 2003
65. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases.
Curr Probl Cardiol 28(5):317-347, May 2003
66. Mukherjee D. CVD, Pharmacogenomics and tailored medical therapy. Geriatric
Times 4(3), 13-14, June 2003
67. Mukherjee D and Eagle, KA. Perioperative Cardiac Assessment for Non-cardiac
Surgery: Eight Steps to the Best Possible Outcome. Circulation 107: 2771 - 2774, June
2003
68. Mukherjee D. Renal Artery Stenosis: Who to Screen and How to Treat? ACC Curr J
Rev 12(3): 70-75, June 2003
16
69. Mukherjee D and Eagle KA. Revised AHA/ACC Guidelines for the Management of
non-ST segment Elevation Acute Coronary Syndromes: Highlights, Clinical Applications
and Controversies. Current Cardiology Reports 5(4): 289-295, July 2003
70. Rajagopalan S, Pfenninger D, Kehrer C, Chakravarti A, Somers E, Pavlic R,
Mukherjee D, Brook R, D’Alecy LG and Kaplan MJ. Increased ADMA and Endothelin
1 levels in secondary Raynaud’s phenomenon: Implications for vascular dysfunction and
progression of disease. Arthritis Rheumatism 48 (7); 1992-2000, July 2003
71. Dey S and Mukherjee D. Clinical perspective on the role of anti-platelet therapy and
statins in patients with vascular diseases. Curr Vasc Pharmacology 1(3); 329-333,
September 2003
72. Bates ER, Mukherjee D and Lau WC. Drug-Drug Interactions Involving Antiplatelet
Agents. Eur Heart J 24 (19); 1707-1709, October 2003
73. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM,
Nallamothu BK, O'Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J,. Meengs
WM, Patel K, and Moscucci M. Impact of Extra-Cardiac Vascular Disease on Acute
Prognosis in Patients Undergoing Percutaneous Coronary Interventions: Data From the
Blue Cross & Blue Shield of Michigan Consortium [BMC2] Am J Cardiol 92 (8), 972-
974, October 2003
74. Nallamothu BK, Chetcuti S, Mukherjee D, Eagle, KA, Grossman P M, Giri K,
McKechnie RS, Kline-Rogers E and Moscucci M. Long-term prognostic implication of
extracardiac vascular disease in patients undergoing percutaneous coronary intervention
Am J Cardiol 92 (8), 964-966, 2003
75. Mukherjee D and Topol EJ. Pharmaceutical Advertising versus Research Spending:
Are Profits more important than Patients. Am Heart J 146, 563-564, October 2003
17
76. Rajagopalan S, Pfenninger D, Somers E, Kehrer C, Chakravarti A, Mukherjee D,
Brook R and Kaplan MJ Effects of cilostazol in patients with Raynaud's syndrome. Am J
Cardiol 92 (11), 1310-1315, December 2003
77. Mukherjee D and Eagle KA. Improving Quality of Care in the Real World –
Efficacy vs Effectiveness? Am Heart J 146 (6), 946-947, December 2003
78. Yee KC, Mukherjee D, Smith DE, Kline-Rogers EM, Fang J, Mehta RH,
Almanaseer Y, Akhras E, Cooper JV, and Eagle KA. Prognostic Significance of an
Elevated Creatine Kinase in the Absence of an Elevated Troponin I During an Acute
Coronary Syndrome Am J Cardiol 92 (12), 1442-1444, December 2003
79. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M and Topol EJ. Risk
Factors for Premature Coronary Artery Disease and Determinants of Adverse Outcomes
after Revascularization in Patients ≤ 40 years of Age Am J Cardiol 92 (12), 1465-1467,
December 2003
80. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, López-
Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ. Elevated
Leukocyte Count and Adverse Hospital Events in Patients with Acute Coronary
Syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE). Am
Heart J 147 (1), 42-48, January 2004
81. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalan S,
Upchurch GR, Stanley JC, and Eagle KA. Patients undergoing infrainguinal bypass for
atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect
on graft patency, limb salvage, and mortality J Vasc Surg 39(2): 357-65, February 2004
82. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle KA.
Impact of Combination Evidence-based Medical Therapy on Mortality in Patients with
Acute Coronary Syndromes Circulation 109(6): 745 – 749, February 2004
18
83. Chen MS, Bhatt DL, Mukherjee D, Chan AW, Roffi M, Kapadia SR, Ziada KM,
Chew DP, Bajzer CT, and Yadav SJ. Safety of Simultaneous Bilateral Carotid Artery
Stenting Cathet Cardiovasc Intervent 61:437–442, April 2004
84. Sarkar S, Leaman DW, Gupta S, Sil P, Young D, Morehead A, Mukherjee D, Ratliff
N, Sun Y, Rayborn M, Hollyfield J, Sen S. Cardiac overexpression of myotrophin
triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem 279
(19):20422-34, May 2004
85. Mukherjee D and Eagle KA. Improving Quality of Cardiovascular Care in the Real
World – How can we Remove the Barriers Am J Managed Care 10(7): 471-472, July
2004
86. Mukherjee D and Eagle KA. Treatment of the Post-Myocardial Infarction Patient
Journal of Clinical Outcomes Management 11(7):436-443, July 2004
87. Mukherjee D and Eagle KA. Ischemia, Revascularization and Peri-operative
Troponin Elevation after vascular Surgery. J Am Coll Cardiol 44(3): 576-578, August
2004
88. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E and Eagle KA.
Optimal Therapy for Acute Coronary Syndromes: The More the Better? Circulation 110:
e52, August 2004
89. Fergus TS, Fazel R, Fang J, Chetcuti S, Smith DE, Kline-Rogers E, Munir K, Eagle
KA, and Mukherjee D. Presentation, Management, and Outcomes of Diabetic Patients
compared to Non-Diabetic Patients Admitted for Acute Coronary Syndromes HEART 90
(9):1051-1052, September 2004
19
90. Badr Al W, Mukherjee D, Kline-Rogers E, Mani O, Hussain S, Mehta R, Cooper
JV, and Eagle KA. Clinical Association between Renal Insufficiency and Positive
Troponin-I in Patients with Acute Coronary Syndrome Cardiology 102: 215-219,
September 2004
91. Mukherjee D, Oz M, Prager R and Eagle KA. Elective Coronary Revascularization:
An Iatrogenic Form of Acute Coronary Syndrome - How can Clinicians Reduce the
Risks? Am Heart J 148(3): 371-377, September 2004
92. Mukherjee D. Role of Emboli protection devices in native coronary and saphenous
vein graft percutaneous interventions. ACC Curr Jnl Rev 13(9), 32-35, September 2004
93. Mukherjee D. Current Clinical Perspectives on Myocardial Angiogenesis. Mol Cell
Biochem 264 (1-2): 157-167, September 2004
94. Saab FA, Eagle KA, Kline-Rogers E, Fang J, Otten R, and Mukherjee, D on behalf
of the Michigan Cardiovascular Outcomes Research and Reporting Program [MCORRP]
of the University of Michigan Cardiovascular Center. Comparison of Outcomes in Acute
Coronary Syndrome in Patients Receiving Statins within 24 Hours of onset - Versus - At
Later Times. American Journal of Cardiology 94(9), 1166-1168, November 2004
95. Mukherjee D and Bates ER. Current Role of Anti-thrombotic Agents in the
Treatment of Acute Coronary Syndromes. Semin Thromb Hemost 30(6): 627-632,
December 2004
96. Almanaseer Y, Mukherjee D, Kline-Rogers E, Mehta RH, Kesterson SK, Sonnad S,
Rogers B, Smith D, Furney S, Ernst R, McCort J and Eagle KE. Implementation of the
ACC/AHA Guidelines for Preoperative Cardiac Risk Assessment in a General Medicine
Preoperative Clinic: Improving Efficiency and Preserving Outcomes Cardiology 103(1):
24-29, January 2005
20
97. Mukherjee D, Kline-Rogers E, Fang J, Munir K, and Eagle KA. Lack of
Clopidogrel - CYP3A4 Statin Interaction in Patients with Acute Coronary Syndrome
HEART 91:23–26, January 2005
98. Mukherjee D, Wainess RM, Dimick JB, Cowan JA Jr, Rajagopalan S, Chetcuti S,
Grossman PM, and Upchurch Gr Jr. Variation in outcomes after Percutaneous Coronary
Intervention in the United States and Predictors of Peri-procedural Mortality Cardiology
103(3):143-147, February 2005
99. Fazel R, Fang J, Kline-Rogers E, Smith DE, Eagle KA, and Mukherjee D.
Prognostic Value of Elevated Biomarkers in Diabetic Compared to Non-Diabetic Patients
Admitted for Acute Coronary Syndromes HEART 91(3):388-90, March 2005
100. Mukherjee D, Fang J, Kline-Rogers E, Otten R and Eagle KA. Impact of
Combination Evidence-based Medical Therapy in Patients with Acute Coronary
Syndromes in Various TIMI Risk Groups HEART 91(3):381-382, March 2005
101. Evangelista A, Mukherjee D, Mehta RH, O’Gara PT, Fattori R, Cooper JV, Smith
DE, Oh JK, Hutchison S, Sechtem U, Isselbacher EM, Nienaber CA, Pape LA, Eagle KA
for the IRAD* Investigators. Acute Intramural Hematoma of the Aorta: A Mystery in
Evolution Circulation ;111:1063-1070, March 1st 2005
102. Mukherjee D, Meier D and Eagle KA. A 40-year old female with exertional angina
J Invasive Cardiology 17(3): 185-186, March 2005
103. Mukherjee D. Percutaneous coronary intervention versus coronary artery bypass
grafting in diabetic patients. Cardiology Clinics of North America 23(2):185-91, May
2005
104. Armstrong D, Kline-Rogers E, Jani SM, Goldman EB, Fang J, Mukherjee D,
Nallamothu BK, Eagle KA. Potential Impact of the HIPAA Privacy Rule on Data
21
Collection in a Registry of Patients With Acute Coronary Syndrome Arch Intern Med
165:1125-1129, May 2005
105. Mukherjee D and eagle KA. Aortic dissection – an Update. Curr Prob in
Cardiology 30(6): 281-326, June 2005
106. Mukherjee D. Optimizing Management of Patients with Coronary Artery Disease -
How do we get there? Eur Heart J 26(12): 1147 – 1149, June 2005
107. Mukherjee D, Munir K, Hirsch AT, Chetcuti S, Grossman PM, Rajagopalan SR,
Nallamothu BK, Moscucci M, Henke P, Kassab E, Sohal C, Riba A Person D, Luciano AE,
DeGregorio M, Patel K, Rutkowski KC, and Eagle KA. Development of a Multicenter
Peripheral Arterial Interventional Database: The Peripheral Vascular Disease Quality
Improvement Initiative (PVD-QI2). American Heart Journal 149(6):1003-1008, June
2005
108. Nallamothu B, Saint M, Saint S and Mukherjee D. Double Jeopardy. New England
J Med 353:75-80, July 2005
109. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M,
Vora N, Tiong I, and Bajzer C. Management of Severe Cardiac and Carotid Disease:
Favorable Outcomes of Carotid Stenting Followed by Open Heart Surgery Versus
Combined Carotid Endarterectomy and Open Heart Surgery. Am J Cardiol 96 (4), 519-
523, August 2005
110. Cho L and Mukherjee D. Use of Hormone Replacement Therapy for the Prevention
of Cardiovascular Disease Events: A meta-analysis of randomized trials. Cardiology
104(3):143-147, August 2005
111. Keast RK, Eagle KA, Goldstein-Dunn J, Cox D, Michalak CG, Chetcuti S,
Grossman PM, Mukherjee D, Larin LR, Fetyko S, Denton TA and Moscucci M. Shelf-
22
Price Agreements: The Next Frontier in Competitive Bidding for Coronary Intervention
Supplies Journal of Cardiovascular Management 16(3):27-30, September 2005
112. Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L and Mukherjee D. Role of
PPAR- γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic
Individuals: A Cardiovascular Perspective. Current Drug Targets - Cardiovascular &
Haematological Disorders, 5(5):377-86, October 2005
113. Otten R, Kline-Rogers E, Meier D, Dumasia R, Fang J, May N, Resin Y, Armstrong
DF, Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic state on
Clinical Outcomes in patients with Acute Coronary Syndromes. HEART 91:1466-1468,
November 2005
114. Mukherjee D, Topol EJ, Bertrand ME, Kristensen SD, Herrmann HC, Neumann
FJ, Yakubov SJ, Bassand JP, McClure RR, Stone GW, Ardissino D, and Moliterno DJ
for the TARGET Investigators. Mortality at 1 year for the direct comparison of tirofiban
and abciximab during percutaneous coronary revascularization: Do Tirofiban and ReoPro
Give Similar Efficacy Outcomes at Trial (TARGET) 1-Year Follow-Up. Eur Heart J
26(23):2524-8, December 2005
115. Tsai TT, Nallamothu BK, Mukherjee D, Rubenfire M, Fang J, Chan P, Kline-
Rogers E, Patel A, Armstrong DF, Eagle KA and Goldberg AD. Effect of Statin Use in
Patients with Acute Coronary Syndromes and a Serum Low-Density Lipoprotein ≤ 80
mg/dl. Am J Cardiol 96(11):1491-3, December 2005
116. Mukherjee D, Evangelista A, Nienaber CA, Sechtem U, Suzuki T, Trimarchi S,
Llovet A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S,
Fattori R, Pape LA, Isselbacher EM, and Eagle KA. Implications of Periaortic
Hematoma in Patients with Acute Aortic Dissection: (From the International Registry of
Aortic Dissection) Am J Cardiol 96(12):1734-8, December 2005
23
117. Mukherjee D. Commentary 2 (Role and appropriate timing of invasive evaluation
in patients with unstable angina and NSTEMI. Evid Based Cardiovasc Med. 9(4):292-3,
December 2005
118. Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L, and
Steinhubl SR. Extra-Cardiac Vascular Disease and Effectiveness of Sustained
Clopidogrel Therapy HEART 92: 49 – 51, January 2006
119. Ramanathan PK, Eagle KA, Fang J, Kline-Rogers EM, Land B, Otten RF, Resin Y,
and Mukherjee D. Smoking Cessation in Patients with Acute Coronary Syndrome.
Indian Heart J; 58: 47-51, February 2006
120. Mukherjee D and Moliterno DJ. Brachytherapy for In-Stent Restenosis - A Distant
Second Choice to Drug-eluting Stent Placement. JAMA 295:1307-1309, March 2006
121. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers E, López-Sendón
J, Agnelli G, Allegrone J, Eagle, MD KA, Mehta RH and Goldberg RJ. Association of
Peripheral Artery Disease With Treatment and Outcomes in Acute Coronary Syndromes.
The Global Registry of Acute Coronary Events (GRACE). Am Heart J 151:1130-1135,
May 2006
122. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R,
Roffi M, and Moliterno DJ. Clinical Outcome of Multivessel Coronary Intervention in
the Contemporary Percutaneous Revascularization Era. Am J Cardiol; 97:1585–1590,
June 2006
123. Cho L and Mukherjee D. Basic Cerebral Anatomy: The Intracranial and
Extracranial Vessels Catheter Cardiovasc Interv 68(1):104-111, June 2006
24
124. Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J and Mukherjee
D. Heparin-induced Thrombocytopenia and Cardiovascular diseases. Am Heart J
152(1):19-26, July 2006
125. Mukherjee D. Continuous Quality Improvement Initiatives in the Cardiac
Catheterization Laboratory – Can We have Our Cake and Eat It Too? Am J Managed
care 12(8):429-30, August 2006
126. Saab FA, Petrina M, Kline-Rogers E, Fang J, Otten R, Mukherjee D and Eagle
KA. Early Statin Therapy in Elderly Patients Presenting with Acute Coronary Syndrome
Causing Less Heart Failure. Indian Heart Journal: 321–324 August 2006
127. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Sneed D, Steinhubl SR, Booth
DC, Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients with End-Stage
Renal Disease Undergoing Percutaneous Coronary Revascularization. J Inv Cardiology
18(9):405-8, Sept 2006
128. Mukherjee D. Does a coxib-associated thrombotic risk limit the clinical use of the
compounds as analgesic anti-inflammatory drugs? Thrombosis and Haemostasis
96(4):407-12, October 2006
129. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW; Satayathum S,
Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D,
Saran R. Peripheral Arterial Disease in Patients with End-Stage Renal Disease -
Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)
Circulation114:1914-1922, October 2006
130. Harada RK, Eagle KA, Kline-Rogers EM, Fang J, Smith D, and Mukherjee D.
Low Utilization of Secondary Preventive Medications and its Potential Impact in Patients
25
with Chronic Kidney Disease and Acute Coronary Syndromes. Indian Heart Journal
2006; 58: 223–230, November 2006
131. Mukherjee D and Moliterno DJ. The Timely Coupling of Mechanical
Revascularization following Thrombolysis for Myocardial Infarction. Cardiology
107:337-339, January 2007
132. Mardikar HM and Mukherjee D. Current Endovascular Treatment of Peripheral
Arterial Disease. Prog Cardiovasc Nursing 22:31–37, March 2007
133. Latchamsetty R, Fang J, Kline-Rogers E, Mukherjee D, Otten RF, LaBounty TM,
Emery MS, Eagle KA, Froehlich JB. Prognostic Value of Transient and Sustained Rise
of In-hospital Creatinine on Outcomes of Patients Admitted with Acute Coronary
Syndrome. Am J Cardiol 99:939 –942, April 2007
134. Mukherjee D and Roffi M. Current Strategies With High Dose Tirofiban Expert
Opinion on Drug Metabolism and Toxicology 3(2):275-280, April 2007
135. Mukherjee D. Designing and Performing Large Multicenter Randomized Clinical
Trials in India: What do we need? Indian Heart J; 59: 113-115, April 2007
136. Roffi M, Brandle M, Robbins MA, and Mukherjee D. Current Perspectives on
Coronary Revascularization in the Diabetic Patient. Indian Heart J; 59: 124-136, April
2007
137. Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC,
Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif
A, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ. Peroxisome proliferator-
activated receptor gamma agonists for the Prevention of Adverse events following
percutaneous coronary Revascularization--results of the PPAR study. American Heart
Journal 154(1):137-43, July 2007
26
138. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G,
Budaj A, Avezum A, Allegrone J, FitzGerald G, Steg PG, on behalf of the GRACE
Investigators. Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of
Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global
Registry of Acute Coronary Events) Am J Cardiol 100(1):1-6, July 2007
139. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath
JS, Deshpande NV, Khan A, Joseph J and Mukherjee D. Optimal Platelet Inhibition in
Patients undergoing PCI: Data from the Multicenter Registry of High-Risk Percutaneous
Coronary Intervention and Adequate Platelet Inhibition (MR PCI) Study. American
Heart Journal 154(2):344.e1-5, August 2007
140. Bhatheja R and Mukherjee D. Acute Coronary Syndromes: Non ST Segment
Elevation Myocardial Infarction. Critical Care Clinics of North America 23(4); 709-735,
October 2007
141. Mukherjee D and Eagle KA. The Use of Antithrombotics for Acute Coronary
Syndromes in the Emergency Department: Considerations and Impact Progress in
Cardiovascular Diseases, 50, (3): 167-180, November – December 2007
142. Mukherjee D and Pineda G. Extracranial Vertebral Artery Intervention. J Interv
Cardiol 20(6):409-16, December 2007
143. Mukherjee D and Moliterno DJ. Effectiveness of Drug-Eluting Stents in Real-
World Patients. JAMA 299(4):454-455, January 2008
144. Roffi M and Mukherjee D. Platelet glycoprotein IIb/IIIa receptor inhibitors – End
of an Era? Eur Heart J 29: 429-431, February 2008
27
145. Mukherjee D. Improving Adherence to Medications - Can We Make This Horse
Drink? Am Heart J 155: 589-590, April 2008
146. Mukherjee D and Roffi M. Glycoprotein IIb/IIIa Receptor Inhibitors in 2008: Do
They Still Have a Role? J Interv cardiology 21(2):118-21, April 2008
147. Mukherjee D. Nonsteroidal Anti-Inflammatory Drugs and the Heart: What Is the
Danger? Congest Heart Fail 14(2): 75-82, April 2008
148. Kim JS, Mukherjee D. Current status of carotid stenting. Curr Vasc Pharmacol
6(2): 143-7, April 2008
149. Mukherjee D. Antithrombotic Agents for Acute Coronary Syndromes.
Cardiovascular and Hematological Agents in Medicinal Chemistry 6 (2):130-141, April
2008
150. Mukherjee D. Optimal Treatment for In-stent Restenosis after BMS – DES, Coated
Balloon or Scalpel? Eur Heart J 29, 1595–1596, July 2008
151. Mukherjee D. Vertebral Artery Interventions. Am Heart Hosp J (in press)
152. Mardikar H, Deo D, Deshpande N, Mardikar M, Ghosh A, Munot K, Steinhubl S,
and Mukherjee D. Variability in platelet response to single daily dose of 150 mg enteric
coated aspirin in high risk population. J Assoc Physicians India (in press)
153. Shah A, Banerjee T and Mukherjee D. Coronary, peripheral and cerebrovascular
disease: a complex relationship. Herz (in press)
154. Mark DB, Berman DS, Lauer MS, Budoff MJ, Miller JM, Carr JJ, Morin RL,
Gerber TC, Mukherjee D, Hecht HS, Poon M, Hodgson JM, Rubin GD, Hlatky MA
Schwartz RS. ACCF/AHA/SCAI/SCCT/SAIP/ACR Clinical Expert Consensus
Document on CT Angiography. J Am Coll Cardiol (in press)
28
155. Mukherjee D. Peripheral and cerebrovascular disease. Best Practice & Research:
Clinical Endocrinology & Metabolism (in press)
156. Mukherjee D. Unraveling the Genetic Predisposition for Aortic Aneurysms - Is it
Time for Tailored Medicine. Am J Hypertens (in press)
Abstracts:
1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of
myocardial hypertrophy in spontaneously hypertensive rats. Circulation 80(4): II -595,
1989 (Presented at the 62nd Scientific session of the American Heart Association).
2. Mukherjee D and Sen S. In Vitro transcriptional enhancement of myosin and
connexin (gap junction protein) by myotrophin. Circulation 82(4): III - 231, 1990
(Presented at the 63rd Scientific session of the American Heart Association).
3. Sen S, Sil P and Mukherjee D. Quantification of myotrophin from spontaneously
hypertensive rat heart. Circulation 84(4): II - 397, 1991 (Presented at the 64th
Scientific session of the American Heart Association).
4. Mukherjee D, McTiernan CF and Sen S. Effect of myotrophin on induction of proto -
oncogenes, ANF and contractile element transcript levels. Circulation 86(4) I - 626,
1992 (Presented at the 65th Scientific session of the American Heart Association).
5. Mukherjee D, Thekkumkara T, Sen G and Sen S. Ontogeny of myotrophin
mRNA in spontaneously hypertensive rat (SHR) hearts. Circulation 86(4) I - 96, 1992
(Presented at the 65th Scientific session of the American Heart Association).
29
6. Silver MJ, Chetcuti S, Mukherjee D, Malycky JL, Tomei DL, Umansky S, and
Nicolini FA. Use of a novel anti-apoptotic agent (LXR017) reduces infarct size following
ischemia-reperfusion in the canine myocardium. J Am Coll Cardiol 31(2) Suppl A, 66A,
1998 (Presented at the 47th Annual Scientific Session of the American College of
Cardiology).
7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ.
Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following
intracoronary stenting. J Am Coll Cardiol 31(2) Suppl A, 100A, 1998 (Presented at the
47th Annual Scientific Session of the American College of Cardiology).
8. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound
enhances PESDA linked oligonucleotide deposition into myocardial tissue. J Am Soc
Echo 11(5) RC, 1998 (Presented at the 9th Annual Scientific Session of the American
Society of Echocardiography).
9. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound power
affects uptake of PESDA linked oligonucleotide deposition into myocardial tissue.
Circulation 98(17) I - 503, 1998 (Presented at the 71st Scientific session of the American
Heart Association).
10. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten
fold augmentation of myocardial uptake of vascular endothelial growth factor with
ultrasound after systemic administration. . J Am Coll Cardiol 33(2) Suppl A, 4A, 1999
(Presented at the 48th Scientific session of the American College of Cardiology as a
Young Investigator Award Finalist).
11. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Vince DG, and Thomas JD.
Endothelial and Smooth Muscle Cell Migration Induced by Vascular Endothelial Growth
Factor with Ultrasound after Systemic Administration. J Am Coll Cardiol 33(2) Suppl A,
30
408A, 1999 (Presented at the 48th Scientific session of the American College of
Cardiology).
12. Mukherjee D, Olano A, Nader S, Garcia M, and Griffin BP. Improvement in right
ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid
regurgitation. J Am Soc Echo 11(5) RC, 1999 (Presented at the 10th Annual Scientific
Session of the American Society of Echocardiography).
13. Mukherjee D, Wang K, Ellis SG, Silver M, Zhou X, Nimrod R, Topol EJ, and
Lincoff AM. Selective Inhibition of Factor Xa is more Efficient than Heparin at
Facilitating Coronary Thrombolysis in a Canine Model. J Am Coll Cardiol ; 35(2): Suppl
A, 373A, 2000 (Presented at the 49th Scientific session of the American College of
Cardiology).
14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Sen S, Porter T, and Thomas JD.
Ultrasound Power Increases Myocardial Vascular Endothelial Growth Factor Uptake in a
Dose Dependent Manner. J Am Coll Cardiol ; 35(2): Suppl A, 494A, 2000 (Presented at
the 49th Scientific session of the American College of Cardiology).
15. Mukherjee D, Reginelli JP, Chew DP, Schneider JP, Raymond R, Whitlow PL,
Franco I, Topol EJ, and Ellis SG. A Potential New Indication for Thienopyridine ADP-
receptor Antagonists: In-stent Restenosis. J Am Coll Cardiol ; 35(2): Suppl A, 84A, 2000
(Presented at the 49th Scientific session of the American College of Cardiology).
16. Mukherjee D, Mahaffey KW, Sparapani R, Dyke C, Roe MT, Moliterno DJ,
Harrington R, Califf R and Topol EJ. The promise of combined LMW heparin and
Platelet glycoprotein IIb/IIIa inhibition – Results from PARAGON B. Circulation
102(18), II - 591, 2000 (Presented at the 73rd Scientific session of the American Heart
Association).
31
17. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R,
Whitlow PL, Franco I, and Ellis SG. Mortality reduction with abciximab for in-stent
restenosis Circulation 102(18), II - 666, 2000 (Presented at the 73rd Scientific session of
the American Heart Association).
18. Cura FA, Kapadia SR, Ziada KM, Mukherjee D, Wolski KE, Bhatt DL, Yadav JS,
Whitlow PL Brener SJ, and Ellis SG. Lesion length and stent caution: Lessons from
randomized trials. Circulation 102(18), II - 387, 2000 (Presented at the 73rd Scientific
session of the American Heart Association).
19. Roffi M, Cura FA, Kapadia SR, Mukherjee D, Bhatt DL, Chew D, Robbins MA,
Albirini A, Wolski KE, and Ellis SG. Extending the temporal window for repeat target
vessel revascularization: Stenting loses ground versus balloon angioplasty after six
months. Circulation 102(18), II - 667, 2000 (Presented at the 73rd Scientific session of
the American Heart Association).
20. Bhatt DL, Mukherjee D, Roffi M, Kapadia SR, Ziada KM, Chew DP, and Yadav JS.
Is Simultaneous Bilateral Carotid Artery Stenting Safe? J Am Coll Cardiol; 37(2): Suppl
A, 50A, 2001 (Presented at the 50th Scientific session of the American College of
Cardiology).
21. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, Topol EJ. Glycoprotein
IIb/IIIa inhibitors in the medical management of unstable ischemic syndromes without
persistent ST-segment elevation: a meta-analysis of the randomized trials. J Am Coll
Cardiol; 37(2): Suppl A, 365A, 2001 (Presented at the 50th Scientific session of the
American College of Cardiology).
22. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG,
Topol EJ. Stents and glycoprotein IIb/IIIa blockade have no salutary effect on 30-day
outcome following percutaneous interventions of coronary bypass grafts. J Am Coll
32
Cardiol; 37(2): Suppl A, 68A, 2001 (Presented at the 50th Scientific session of the
American College of Cardiology).
23. Roffi M, Chan A, Chew DP, Robbins MA, Mukherjee D, Bhatt DL, Albirini A, Cho
L, Agah R, Topol EJ, Ellis SG. Stents and glycoprotein IIb/IIIa inhibitors do not improve
30-day outcome in bypass graft percutaneous interventions: a retrospective registry-based
analysis. J Am Coll Cardiol; 37(2): Suppl A, 77A, 2001 (Presented at the 50 th Scientific
session of the American College of Cardiology).
24. Roffi M, Mukherjee D, Bhatt DL, Chew DP, Ziada KM, Prosper DM, Ellis SG,
Topol EJ. Percutaneous coronary interventions of coronary bypass grafts have doubled
major adverse events. J Am Coll Cardiol; 37(2): Suppl A, 6A, 2001 (Presented at the 50th
Scientific session of the American College of Cardiology).
25. Robbins MA, Chew DP, Bhatt DL, Mukherjee D, Roffi M, Schneider JP, Topol EJ,
Ellis SG. ADP-antagonists therapy added to aspirin prior to coronary intervention
markedly attenuates the risk associated with baseline CRP status. J Am Coll Cardiol;
37(2): Suppl A, 28A, 2001 (Presented at the 50th Scientific session of the American
College of Cardiology).
26. Chew DP, Robbins MA, Bhatt DL, Mukherjee D, Roffi M, Topol EJ, Ellis SG. CRP
provides prognostic value in addition to ACC/AHA lesion score following PCI. J Am
Coll Cardiol; 37(2): Suppl A, 22A, 2001 (Presented at the 50th Scientific session of the
American College of Cardiology).
27. Kapadia S, Ziada KM, Crowe TD, Mukherjee D, Hobbs RE, Nissen SE, Tuzcu EM.
Total plaque Burden in early atherosclerosis: Can it be predicted by the most severe
lesion? J Am Coll Cardiol; 37(2): Suppl A, 63A, 2001 (Presented at the 50 th Scientific
session of the American College of Cardiology).
33
28. Mukherjee D, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, Krieger D,
Whitlow P and Yadav JS. Treatment of Symptomatic Vertebral Artery Stenosis with
Angioplasty and Stenting. (Presented at the International Course on carotid Angioplasty,
Frankfurt/Offenbach, Germany, March 1-3, 2001).
29. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C,
Krieger D, Whitlow P and Yadav JS. Self-expanding stents for carotid intervention:
Comparison of Nitinol versus stainless steel stents. (Presented at the International Course
on carotid Angioplasty, Frankfurt/Offenbach, Germany, March 1-3, 2001).
30. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG,
Topol EJ. Effects of stenting and glycoprotein IIb/IIIa on bypass graft interventions:
Pooled analysis of five randomized glycoprotein IIb/IIIa trials. (Presented at the Swiss
Society of Cardiology Meeting, March 23 –30, 2001). Kardiovaskulare Medizin; 4:
Suppl 3, 2001.
31. Bhatt DL, Kapadia SR, Chew DP, Mukherjee D, Ziada KM, Topol EJ, Yadav SJ.
Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. Eur
Heart J; 22 (Suppl), p 634, 2001 (Presented at the 23rd Annual Congress of the
European Society of Cardiology 2001).
32. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Penn MS, Ellis SG. Intravenous
Infusion of Vascular Endothelial Growth Factor (VEGF) With Ultrasound Energy and
Echo Contrast Agent Improves Myocardial Blood Flow and Decreases Infarct Size in a
Canine Model of Chronic Myocardial Ischemia. Am J Cardiol 88 (5) Suppl 1, p 86G
[Presented at the Transcatheter Cardiovascular Therapeutics (TCT 2001) Meetings].
33. Chan AW, Quinn MJ, Mukherjee D, Moliterno DJ, and Ellis SG. Striking mortality
benefit of -blockade after successful elective percutaneous coronary intervention
Circulation 104(17), II - 711, 2001 (Presented at the 74th Scientific session of the
American Heart Association).
34
34. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro
F, Yadav JS. Renal Artery end-diastolic velocity and renal artery resistance index
predicts outcome after renal artery stenting. Circulation 104(17), II–584, 2001 (Presented
at the 74th Scientific session of the American Heart Association).
35. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, White JA, Heeschen C,
Hamm CW, Theroux P, Topol EJ. Glycoprotein IIb/IIIa inhibitors reduce mortality in
diabetic patients with unstable ischemic syndromes. Circulation 104(17), II - 782, 2001
(Presented at the 74th Scientific session of the American Heart Association).
36. Roffi M, Mukherjee D, Chew DP, Robbins MA, Cho L, Agah R, Chan AW, Quinn
MJ, Ellis SG. Procedural success and outcome of percutaneous coronary intervention of
arterial bypass grafts. Circulation 104(17), II - 776, 2001 (Presented at the 74th
Scientific session of the American Heart Association).
37. Roffi M, Mukherjee D, Chan AW, Yadav SJ. Can ultrasound accurately predict
restenosis after carotid artery stenting? Circulation 104(17), II - 583, 2001 (Presented at
the 74th Scientific session of the American Heart Association).
38. Abou-Chebl A, Reginelli J, Mukherjee D, Bhatt D, Bajzer C, and Yadav J. Cerebral
hyperperfusion and intracranial hemorrhage following internal carotid artery stenting. J
Am Coll Cardiol; 39(5): Suppl A, 68A, 2002 (Presented at the 51st Scientific session of
the American College of Cardiology).
39. Chan A, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray B, Bajzer C, and
Yadav SJ. Percutaneous treatment for pacemaker lead related SVC syndrome. J Am Coll
Cardiol; 39(5): Suppl A, 99A, 2002 (Presented at the 51st Scientific session of the
American College of Cardiology).
35
40. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V,
Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Improved Outcome of Acute
ST-segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery
Bypass Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet
Glycoprotein IIb/IIIa Inhibition. J Am Coll Cardiol; 39(5): Suppl A, 293A, 2002
(Presented at the 51st Scientific session of the American College of Cardiology).
41. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Ellis K, Chan A, Penn MS,
Ostensen J, Thomas JD, Garcia M, Topol EJ, and Ellis SG. Induction of Angiogenesis in
a Canine Model of Chronic Myocardial Ischemia With Intravenous Infusion of Vascular
Endothelial Growth Factor (VEGF) Combined With Ultrasound Energy and Echo
Contrast Agent. J Am Coll Cardiol; 39(5): Suppl A, 396A, 2002 (Presented at the 51st
Scientific session of the American College of Cardiology).
42. Sheikh MA, Navarro F, Mukherjee D, Bajzer C, Yadav J. Percutaneous Intervention
for Occlusive Subclavian Artery Disease. J Am Coll Cardiol; 39(5): Suppl A, 6A, 2002
(Presented at the 51st Scientific session of the American College of Cardiology).
43. Kapadia SR, Ziada KM, Mukherjee D, Nissen SE, and Tuzcu EM. Limitation of
Intravascular Ultrasound in Determining Artery Size: Role of Distension Pressure. J Am
Coll Cardiol; 39(5): Suppl A, 12A, 2002 (Presented at the 51st Scientific session of the
American College of Cardiology).
44. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL,
Ghaffari S, and Yadav J. Bilateral carotid brachytherapy for in-stent restenosis
(Presented at the 13th annual meeting of the Society for Vascular Medicine and Biology
Annual Meeting, Boston, MA).
45. Mukherjee D, Smith D, Share D, Kline-Rogers E, Eagle KA, Chetcuti S, Grossman
P Michael, and Moscucci M. Significantly higher mortality in patients with IDDM
compared to patients with NIDDM and non-diabetics undergoing coronary interventions.
36
Eur Heart J 23: Suppl, pp 610, 2002 (Presented at the European society of Cardiology
Congress, September 2002, Berlin, Germany).
46. Mukherjee D, Smith D, Chetcuti S, Share D, Kline-Rogers E, Eagle KA, Grossman
P Michael, Moscucci, M. Lack of benefit of intravenous GP IIb/IIIa inhibitors in diabetic
patients undergoing PCI is explained by differences in baseline characteristics. Eur Heart
J 23: Suppl, pp 317, 2002 (Presented at the European society of Cardiology Congress,
September 2002, Berlin, Germany).
47. Mukherjee D, Smith D, Kline-Rogers E, Chetcuti S, Eagle KA, Grossman P
Michael, Share D, Moscucci M. Significant mortality benefit of prior beta-blocker use in
diabetic patients undergoing coronary intervention. Eur Heart J 23: Suppl, pp 317, 2002
(Presented at the European society of Cardiology Congress, September 2002, Berlin,
Germany).
48. Nallamothu BK, Chetcuti S, Mukherjee D, Grossman P M, Werns S, Bates E, and
Moscucci M. Impact of serum troponin-I elevation on long term survival following
percutaneous coronary intervention. Eur Heart J 23: Suppl, pp 155, 2002 (Presented at
the European society of Cardiology Congress, September 2002, Berlin, Germany).
49. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, O'Donnell M, De Franco A,
Maxwell-Eward A, McGinnity J, Meengs WM, Patel K, Moscucci M. Prognostic
Implications of Extra-Cardiac Vascular Disease in Patients Undergoing Coronary
Interventions: Insights From the Blue Cross & Blue shield of Michigan Consortium
[BMC2] Circulation 106(19), II - 492, 2002 (Presented at the 75th Scientific session of
the American Heart Association).
50. Mukherjee D, Froehlich JB, Avezum A, Lopez-Sendon J, Kline-Rogers EM,
Johnson J, Mehta RH. Prognostic Implications of Peripheral Vascular Disease in Patients
with Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary
37
Events [GRACE] Circulation 106(19), II - 678, 2002 (Presented at the 75th Scientific
session of the American Heart Association).
51. Mukherjee D, Dey S, Lingam P, Chetcuti S, Grossman PM, Moscucci M,
Rajagopalan S, Luciano AE, Eagle KA. Predictors of Clinical Outcome in Patients
Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan
Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) J Am Coll
Cardiol; 41(6): Suppl A, 75A, 2003 (Presented at the 52nd Scientific session of the
American College of Cardiology).
52. Chetcuti S, Grossman PM, Mukherjee D, Lingam P, Kline-Rogers E, Share D,
Moscucci M. Improving Outcome of Percutaneous Coronary Intervention Through
Application of Guidelines and Benchmarking: Reduction of Blood Transfusion as a
Model J Am Coll Cardiol; 41(6): Suppl A, 527A, 2003 (Presented at the 52nd Scientific
session of the American College of Cardiology).
53. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, Lopez-Sendon
J, Johnson J, Eagle KA, Mehta RM. Quality of Care for Patients With Peripheral
Vascular Disease (PVD) During Acute Coronary Syndromes (ACS): Insights From the
Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol; 41(6): Suppl
A, 252A, 2003 (Presented at the 52nd Scientific session of the American College of
Cardiology).
54. Rajagopalan S, Pfenninger D, Kehrer C, Somers E, Chakraborti A, McCune WJ,
Mukherjee D, Brook RD, Kaplan M. Cilostazol in Raynaud’s Disease-A Double-Blind
Placebo Controlled Clinical Trial. J Am Coll Cardiol; 41(6): Suppl A, 304A, 2003
(Presented at the 52nd Scientific session of the American College of Cardiology).
55. Moscucci M, Smith D, Mukherjee D, Montoye C, O'Donnell MJ, DeFranco AC,
Meengs WL, Maxwell-Eward A, McGinnity JG, Patel K, Share D, For The Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2). Relationship Between
38
Time Of Day/Day Of Week And Outcomes In Patients Undergoing Primary PCI For
Acute Myocardial Infarction. J Am Coll Cardiol; 41(6): Suppl A, 541A, 2003 (Presented
at the 52nd Scientific session of the American College of Cardiology).
56. Zhou X, Mukherjee D, Zhou Z, Lincoff AM, Wang K . A combination of a
selective factor Xa inhibitor and full dose tPA is more effective than heparin and full
dose tPA at facilitating coronary thrombolysis in a canine model. Eur Heart J 23: Suppl,
pp 317, 2003 (Presented at the European society of Cardiology Congress, September
2003, Vienna, Austria).
57. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers E, Lins S, Draus C, Share D,
Chetcuti S, Grossman PM, and Moscucci M. A Simple Risk Score for Predicting
Mortality in Diabetic Patients Undergoing Percutaneous Coronary Intervention
Circulation 108(17), IV-717, 2003 (Presented at the 76th Scientific session of the
American Heart Association).
58. Fox KA, Gore JM, Montalescot G, Mukherjee D, Gowda N, Steg G Ph, for the
GRACE Investigators. Impact of Insulin Treatment on Patients with ST-Segment
Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events
Circulation 108(17), IV-746, 2003 (Presented at the 76th Scientific session of the
American Heart Association).
59. Chetcuti SJ, Mukherjee D, Smith DE, Grossman PM, Bates ER, Duvernoy CJ,
Eitzman DT, and Moscucci M. Development of a Continuous Quality Improvement
Program for the Reduction of Contrast Nephropathy After Percutaneous Coronary
Intervention Circulation 108(17), IV-769, 2003 (Presented at the 76th Scientific session
of the American Heart Association).
60. Ziada KM, Yadav JS, Lauer MS, Bhatt DL, Kapadia SR, Mukherjee D, Roffi M,
Vora N, Tiong I and Bajzer C. Improved Outcomes with Carotid Stenting Prior to Open
Heart Surgery Compared to Combined Carotid Endarterectomy and Open Heart Surgery
39
Circulation 108(17), IV-632, 2003 (Presented at the 76th Scientific session of the
American Heart Association).
61. Mukherjee D, Giri K, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle
KA. Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients
With Acute Coronary Syndromes J Am Coll Cardiol; 43(5): Suppl A, 298A, 2004
(Presented at the 53rd Scientific session of the American College of Cardiology).
62. Nallamothu BK, Mukherjee D, Chetcuti S, Grossman PM, Dumasia R, Kline-Rogers
E, Pitt B, Eagle KA and Moscucci M. Combination Evidence-Based Therapy Improves
Survival After Percutaneous Coronary Intervention J Am Coll Cardiol; 43(5): Suppl A,
421A, 2004 (Presented at the 53rd Scientific session of the American College of
Cardiology).
63. Patel D, Chetcuti S, Grossman P M, Mukherjee D, and Bates E. Catheter Sequence
Rather Than Catheter Shape Determines The Frequency Of Cerebral Microemboli
During Cardiac Catheterization J Am Coll Cardiol; 43(5): Suppl A, 471A, 2004
(Presented at the 53rd Scientific session of the American College of Cardiology).
64. Saab F, Fang J, Kline-Rogers E, Otten R, Eagle KA, and Mukherjee D. Early
[within 24 hours] Statin Administration in Patients Presenting with Acute Coronary
Syndrome is Associated with Better Outcomes Compared to Delayed [after 24 hours]
Administration Circulation 110(17), Suppl III, III-498, 2004 (Presented at the 77 th
Scientific session of the American Heart Association).
65. Harada RK, Kline-Rogers EM, Fang J, Otten R, and Mukherjee D. Use of Evidence-
Based Therapies in Patients with Chronic Kidney Disease Presenting with Acute
Coronary Syndrome and Its Impact on Clinical Outcomes. Circulation 110(17), Suppl
III, III-576, 2004 (Presented at the 77th Scientific session of the American Heart
Association).
40
66. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, May N, Resin Y, Sweis R, Fang J,
Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic State on Clinical
Outcomes in Patients With Acute Coronary Syndrome J Am Coll Cardiol; 45(3): Suppl
A, 198A, 2005 (Presented at the 54th Scientific session of the American College of
Cardiology).
67. Mukherjee D, Eagle KA, Evangelista A, Sechtem U, Suzuki T, Trimarchi S, Llovet
A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R,
Pape LA, Isselbacher EM, Nienaber CA on behalf of the International Registry of Aortic
Dissection (IRAD) investigators. Implications of Periaortic Hematoma in Patients With
Acute Aortic Dissection: Insights From the International Registry of Aortic Dissection
(IRAD) J Am Coll Cardiol; 45(3): Suppl A, 380A, 2005 (Presented at the 54th Scientific
session of the American College of Cardiology).
68. Tsai TT, Nallamothu BK, Grossman PM, Mukherjee D, Chetcuti S, Moscucci M,
and Bates ER. Does Facilitated Percutaneous Coronary Intervention Improve
Angiographic and Clinical Outcomes in ST Elevation Myocardial Infarction? A
Quantitative Review. J Am Coll Cardiol; 45(3): Suppl A, 243A, 2005 (Presented at the
54th Scientific session of the American College of Cardiology).
69. Mukherjee D, Eagle KA, Kline-Rogers E, Agnelli G, Budaj A, Avezum A,
Allegrone J, Steg Ph G on behalf of the GRACE Investigators. Acute Coronary
Syndrome as a Manifestation of Global Atherosclerosis – Impact of Prior Peripheral
Arterial Disease and Stroke on Clinical Outcomes. The Global Registry of Acute
Coronary Events (Presented at the European society of Cardiology Congress, September
2005, Stockholm, Sweden).
70. Jones N, Mukherjee D, Moscucci M, Froehlich JB, Chetcuti SJ, Munir K, Riba A,
Person D, Bishop M, Karve M, and Grossman PM. If Not Now, When? Underutilization
of Evidence Based Therapies in Patients Without Prior History of Coronary Artery
41
Disease Undergoing Peripheral Vascular Intervention. Circulation 112(17), Suppl II, II-
797, 2004 (Presented at the 78th Scientific session of the American Heart Association).
71. Latchamsetty R, Mukherjee D, Fang J, Kline-Rogers E, Otten R, Eagle KA,
Froehlich JB. Prognostic Value of Transient and Sustained Rise of In-Hospital Creatinine
on Outcomes of Patients Admitted with Acute Coronary Syndrome Circulation 112(17),
Suppl II, II-526, 2004 (Presented at the 78th Scientific session of the American Heart
Association).
72. Fazel R, Mukherjee D, Saab F, May N, Kline-Rogers EM, Rogers BC, Fang J,
Erickson S, Eagle KA. Improved Prescription of Evidence-Based Medications and
Maintenance of High Adherence to These Medications in Acute Coronary Syndrome
Patients After Implementation of Guidelines Applied in Practice J Am Coll Cardiol;
47(4): Suppl A, 254A, 2006 (Presented at the 55th Scientific session of the American
College of Cardiology).
73. Das P, Moliterno DJ, Sneed D, Charnigo R, Mukherjee D, Steinhubl SR, Booth DC
and Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients With End-Stage
Renal Disease Undergoing Percutaneous Coronary Revascularization J Am Coll Cardiol;
47(4): Suppl B, 28B, 2006 (Presented at the 55th Scientific session of the American
College of Cardiology).
74. Jones NJ, Mukherjee D, Chetcuti SJ, Froehlich JB, Gurm H, Munir K, Luciano A,
Riba A, Kassab EH, Sohal C, Person D, Karve M, Bishop M, Dunning D, Schaefer A,
Moscussi and Grossman PM. Sex and Peripheral vascular Intervention: Does gender
impact peri-procedural outcomes? Circulation (Presented at the 7th Scientific Forum on
quality of care and outcomes research in cardiovascular disease and stroke).
75. Mukherjee D, Kline-Rogers E, Eagle KA, Feldman LJ, Juliard JM, Allegrone J, and
Steg PG. Acute coronary syndrome as a manifestation of global atherosclerosis: impact
of combination evidence-based therapy on mortality and morbidity in acute coronary
42
syndrome. The GRACE registry Eur Heart J, 27 (Suppl 1), 224, August 2006 (Presented
at the European society of Cardiology Congress, September 2006, Barcelona, Spain).
76. Das P, Ziada K, Hanna E, Falluji N, Booth D, Moliterno DJ and Mukherjee D. Do
octogenarians benefit from drug eluting stents? Am J Cardiol 98(8), Suppl 1, TCT 434,
October 2006 (Presented at the Transcatheter Cardiovascular Therapeutics Symposium,
October 2006, Washington, DC).
77. Dawson CB, Mukherjee D, Valgimigli M, Charnigo R, Walters DL, Danzi GB,
Bolognese L, Moliterno DJ, and Topol EJ. Meta-analysis of High-dose Single-bolus
Tirofiban versus Abciximab in Patients undergoing Percutaneous Coronary Interventions.
Circulation 114 (18), Suppl, II-647 (Presented at the 79th Scientific session of the
American Heart Association, 2006).
78. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath
JS, Deshpande NV, Khan A, Joseph J, Mukherjee D. Optimal Platelet Inhibition in
Patients Undergoing Percutaneous Coronary Intervention: Data From the MR PCI Study.
J Am Coll Cardiol; 49(9): Suppl B, 34B, 2007 (Presented at the 56 th Scientific session of
the American College of Cardiology).
79. Mardikar HM, Deo D, Deshpande NV, Mardikar M, Steinhubl SR and Mukherjee
D. Variability in platelet response to single daily dose of 150 mg aspirin in high risk
population. Eur Heart J, 28 (Suppl 1), 664, August 2007 (Presented at the European
society of Cardiology Congress, September 2007, Vienna, Austria).
Books
Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine.
Philadelphia, PA: Lippincott Raven, 2004
43
Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London,
UK, Martin Dunitz, 2005
Mukherjee D (ed). ECG Cases pocket book. Germany, Borm Bruckmeier Publishing
LLC, 2006
Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology
board review. Philadelphia, PA: Lippincott Raven, 2006
Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the Peripheral
Circulation: Practical Approach with Clinical Protocols, London, Taylor and Francis,
2007
Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and
Results. Bremen, UNI-MED Publishing, 2008
Mukherjee D, Bates ER, Roffi, M and Moliterno DJ. Cardiac Catheterization, Coronary
& Peripheral Angiography, and Interventional Procedures. London, Informa Healthcare,
2009
Multimedia
CATHSAP 3, Associate Editor
ACCSAP 7, Section editor, Cardiac Catheterization and Interventional Cardiovascular
Medicine
Book Chapters:
1. Mukherjee D. Complications of Acute Myocardial Infarction. In Marso S, Griffin BP,
Topol EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven,
1999, pp 39 – 55.
44
2. Mukherjee D. Temporary Transvenous Pacemakers. In Marso S, Griffin BP, Topol
EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven, 1999,
pp 666 – 669.
3. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ eds. Acute
Coronary Syndromes (2nd Edition). New York, NY: Marcel Dekker, 2000, pp 563 –597
4. Mukherjee D, Wilkoff BL, Yadav JS. Angioplasty and Stenting of a Patient with
Superior Vena Cava Syndrome. In: Fifty Cases in Peripheral Intervention. ed:
Christopher White, MD, Martin Dunitz: London, 2002, pp 61-65
5. Mukherjee D and Yadav SJ. Cerebrovascular Diseases: Pathophysiology and
Management. In Fuster V ed. Assessing and modifying the vulnerable atherosclerotic
plaque. Armonk, NY: Futura Publishing, 2002, pp 29-55
6. Mukherjee D and Ellis SG. Rescue PCI for failed thrombolysis. In Cannon C, Tcheng
JE, eds. Primary Angioplasty in Acute Myocardial Infarction. Totowa, NJ: Humana
Press, 2002, pp 53-64
7. Mukherjee D and Yadav SJ. Status of randomized trials - SAPPHIRE. In Amor M,
Bergeron P, Mathias K and Raithel D, eds. Carotid Artery: Angioplasty and stenting
Turin, Italy: Edizioni Minerva Medica, 2002, pp 268-272
8. Mukherjee D. Device Genomics. In Topol EJ, Textbook of Interventional Cardiology
(4th Edition). Philadelphia, PA: W.B. Saunders, 2002, pp 1043-1052
9. Mukherjee D, Bates ER, and Hochman JS. Cardiogenic Shock – SHOCK Trial
Perspective. In Morrison D ed. High risk cardiac revascularization and clinical trials.
London, UK, Martin Dunitz, 2002, pp 327-335
45
10. Mukherjee D. Coronary Artery Disease In Cho L, Griffin B and Topol EJ (eds) The
Cardiology Intensive Board Review Question Book. Philadelphia, PA: Lippincott Raven,
2003, pp 105 – 157
11. Roffi M and Mukherjee D. Glycoprotein IIb/IIIa inhibitors. In de Marchena E and
Ferreira (eds), Interventional Cardiology Secrets. Philadelphia, PA: Hanley & Belfus,
Inc., 2003, pp 81-84
12. Mukherjee D and Bates ER. Acute ST elevation myocardial infarction. In Eagle KA,
Practical Cardiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp 170-
187
13. Mukherjee D. Cardiovascular system. In Haessler I and Maute C (eds). Drug
Therapy Pocket 2003-2004. Hermosa beach, CA: Borm Bruckmeier Publishing, 2003, pp
11-42.
14. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting. In Heuser RR and
Henry M. Textbook of peripheral vascular intervention. London, UK: Martin Dunitz,
2003, pp 333-339
15. Dumasia R and Mukherjee D. Adjunctive Pharmacology such as antithrombotics,
vasodilators, sedation/pain medication, pressors. In Bhatt DL (ed). Essential Concepts in
cardiovascular Intervention: Self Assessment and Review, Remedica Publishing 2003, pp
115-127
16. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients
with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In
Fuster V, Roberts R, Alexander RW, O’Rourke R, King S, Nash I and Prystowski E
(eds) Hurst’s The Heart 11th Edition, Philadelphia, PA: McGraw-Hill, 2004, pp 2037-
2049
46
17. Mukherjee D and Asher C. (Section Editors) Miscellaneous Conditions. In: Roffi M,
Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to
CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004.
18. Mukherjee D and Eagle KA. Cardiac Risk in Non-cardiac Surgery. In: Roffi M,
Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to
CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004.
19. Mukherjee D. Diagnostic Catheter-based Vascular Angiography. In Rajagopalan S,
Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA:
Lippincott Raven, 2004, pp 28-47
20. Mukherjee D, Olin J, and Rajagopalan SR. Renovascular Disease – Diagnosis and
Management. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular
Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 120-134
21. Roffi M and Mukherjee D. Approach to carotid Artery disease. In Rajagopalan S,
Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA:
Lippincott Raven, 2004, pp 135-155
22. Mukherjee D and Rajagopalan SR. Subclavian, Innominate and Axillary Arterial
Disease. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular
Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 227-237
23. Mohler E, Mukherjee D, and Rajagopalan SR. Upper Extremity Deep Vein and
Superior Vena Cava (SVC) Thrombosis In Rajagopalan S, Mohler E and Mukherjee D
(eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 325-
335
47
24. Dumasia R and Mukherjee D. Hemodialysis Access. In Rajagopalan S, Mukherjee D
and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven,
2004, pp 390-397
25. Mukherjee D and Cho L. Renal and mesenteric artery stenosis. In Bhatt DL (ed).
Handbook of peripheral and cerebrovascular intervention, Remedica Publishing 2004, pp
107-121
26. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ (ed).
Acute Coronary Syndromes (3rd Edition). New York, NY: Marcel Dekker, 2004, pp 481-
505
27. Mukherjee D and Eagle KA. Pre and Post-operative Management of Cardiovascular
Diseases and Risks in Patients with Peripheral Vascular Disease. In Abela G, Textbook
of Peripheral Vascular Diseases, Philadelphia, PA: W.B. Saunders, 2004, pp 353-364
28. Mukherjee D. Peripheral Vascular Occlusive Disease (PVOD) – Claudication. In
Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia,
PA: Lippincott Williams & Wilkins, 2005, pp 231-235
29. Mukherjee D. Arterial venous fistula in Groin Following Cardiac catheterization. In
Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia,
PA: Lippincott Williams & Wilkins, 2005, pp 259-264
30. Mukherjee D. Arthritis and Cardiovascular Events. In Topol EJ (ed). Textbook of
Cardiovascular Medicine – Update Series, Volume 8; Number 2, Philadelphia, PA:
Lippincott Williams & Wilkins, 2005, pp 1- 14
31. Mukherjee D and Moliterno DJ. Monitoring Anticoagulants in the Catheterization
Laboratory and in the ICU when using Combination Therapies. In Becker RC,
48
Harrington RA (eds) The Practice of clinical, interventional, and investigational
thrombocardiology. Philadelphia, PA: W.B. Saunders, 2005, pp 257-273
32. Mukherjee D and Eagle KA. Practical Principles of Quality Measurement and Cost
Effectiveness Analysis in Cardiovascular Medicine and Surgery. In ACCSAP VI
[American College of Cardiology], 2005, pp 1-22
http://www.acc.org/education/products/accsap6_chapters.htm
33. Mukherjee D. Lifestyle Changes and Risk factor Modification. In Mukherjee D (ed)
Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Taylor &
Francis, 2005, pp 3-10
34. Eagle K and Mukherjee D. Pharmacotherapy for Global Cardiovascular Risk
Reduction. In Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular
Diseases, London, UK, Taylor & Francis, 2005, pp129-138
35. Pitt B, Mukherjee D and Rajagopalan SR. Renin-Angiotensin-Aldosterone-System
[RAAS] Blockade in Peripheral Arterial Diseases. In Mukherjee D (ed) Pharmacological
Therapies for Peripheral Vascular Diseases, London, UK, Taylor & Francis, 2005, pp 65-
74
36. Mukherjee D and Eagle KA. Preoperative Cardiac Assessment In Zelenock,
Lumsden, Messina, Moneta, and Huber (eds) Mastery of Vascular and Endovascular
Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 47-54
37. Mukherjee D and Rosenfield K. Vertebral Artery Intervention. In Casserly I, Sachar
R and Yadav J (eds). The Manual of Peripheral Vascular Intervention. Philadelphia, PA:
Lippincott Williams & Wilkins, 2005, pp 110-119
49
38. Mukherjee D and Eagle KA. Aortic Dissection In Bax, Kramer, Marwick and Wijns
(eds) Optimal Use of cardiovascular Imaging in Clinical Practice, Victoria, Australia,
Blackwell Publishing, Malden, MA, 2005, pp 49-60
39. Saraff KY, Mukherjee D, Moliterno DJ. Monitoring of Anti-thrombotic Drugs, In
Kristensen SD, Caternia R De, Moliterno DJ (eds). Therapeutic Strategies in
Thrombosis, Oxford, UK, Clinical Publishing Co., Inc., 2005, pp 359-383
40. Mukherjee D. Emerging Treatment Modalities in Coronary Artery Disease. In Kohli
K, Gupta M and Tejwani S (eds). Current Therapeutics in Clinical Practice, New Delhi,
India, Elsevier, 2006, pp 282-292.
41. Mukherjee D and Eagle KA. Assessment of Preoperative Risk. In Mulholland MW,
Doherty GM (eds). Complications in Surgery, Philadelphia, PA: Lippincott Williams &
Wilkins, 2006, pp 57-66
42. Falluji N and Mukherjee D. Cerebrovascular interventions. In Mukherjee D, Cho L,
Moliterno DJ (eds). 900 Questions: An interventional cardiology board review.
Philadelphia, PA: Lippincott Raven, 2006, pp 225-232
43. Cho L and Mukherjee D. Closure Devices. In Mukherjee D, Cho L, Moliterno DJ
(eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA:
Lippincott Raven, 2006, pp 164-169
44. Mukherjee D, Moliterno DJ, Cho L Primary, Rescue and Facilitated Angioplasty In
Mukherjee D, Moliterno DJ, Cho L (eds). 900 Questions: An interventional cardiology
board review. Philadelphia, PA: Lippincott Raven, 2006, pp 88-96
45. Das P, Dutta M and Mukherjee D. Heparin-induced Thrombocytopenia In ACCSAP
VI [American College of Cardiology]
http://www.cardiosource.com/GenSAP/Chapter.asp?ProductID=40&ChapterID=2207
50
46. Das P, Dutta M and Mukherjee D. Hypercoaguable Syndromes. In ACCSAP VI
[American College of Cardiology]
http://www.cardiosource.com/GenSAP/Chapter.asp?ProductID=40&ChapterID=2207
47. Mukherjee D and Januzzi JL. Long-term Medical Therapy in Aortic Dissection In
Baliga, Isselbacher, Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer
Academic Publishers, 2007, pp 193-198
48. Mukherjee D and Eagle KA. Prevention of Aortic Dissection In Baliga, Isselbacher,
Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer Academic
Publishers, 2007, pp 347-350
49. Falluji N and Mukherjee D. Lower extremity interventions. In Topol EJ, Textbook
of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp
689-708
50. Das P and Mukherjee D. Bioabsorbable stents. In Topol EJ, Textbook of
Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp 601-
618
51. Ziada K and Mukherjee D. Peri-Procedural MI and Emboli Protection. In Topol EJ,
Textbook of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders,
2007, pp 491-512
52. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients
with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In
Fuster V, O’Rourke R, Walsh RA and Poole-Wilson PA (eds) Hurst’s The Heart 12th
Edition, Philadelphia, PA: McGraw-Hill, 2007, pp 2038-2047
51
53. Mukherjee D and Rajagopalan SR. X-Ray Contrast Agents and Contrast Timing
Considerations. In Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the
Peripheral Circulation: Practical Approach with Clinical Protocols, London, Taylor and
Francis, 2007, pp 53-62
54. Nallamothu B, Mukherjee D and Bates ER. Acute ST elevation myocardial
infarction. In Eagle KA, Practical Cardiology (2nd Edition). Philadelphia, PA: Lippincott
Williams & Wilkins, 2003, pp 196-218
55. Mukherjee D and Moliterno DJ. Heparin-induced Thrombocytopenia In CATHSAP
3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008
http://www.acc.org/education/products/cathsap3.htm
56. Mukherjee D and Moliterno DJ. Hypercoagulable Disorders In CATHSAP 3
[Catheterization and Interventional Cardiology Self-Assessment Program], 2008
http://www.acc.org/education/products/cathsap3.htm
57. Moliterno DJ and Mukherjee D. Chronic Total Occlusion In CATHSAP 3
[Catheterization and Interventional Cardiology Self-Assessment Program], 2008
http://www.acc.org/education/products/cathsap3.htm
58. Mukherjee D. Aortic Dissections In CATHSAP 3 [Catheterization and
Interventional Cardiology Self-Assessment Program], 2008
http://www.acc.org/education/products/cathsap3.htm
59. Pineda G and Mukherjee D. Lower extremity: Contrast imaging studies. In Richard
Heuser and Michel Henry (Eds) Textbook of Peripheral Vascular Interventions 2nd
edition, London, Taylor and Francis, 2008
52
60. Mukherjee D. Cardiovascular Disease in patients with carotid stenosis. In Roffi M,
Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results.
Bremen, UNI-MED Publishing, 2008
61. Mukherjee D. Carotid Stenting Equipment. In Roffi M, Abou-Chebl A and
Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED
Publishing, 2008
62. Mukherjee D. Secondary Prevention and follow-up. In Roffi M, Abou-Chebl A and
Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED
Publishing, 2008
63. Das P and Mukherjee D. Coronary artery disease in Peripheral Arterial Disease. In
Dieter RS (ed) Peripheral Arterial Disease. McGraw-Hill Professional, 2008
64. Dawson CB, Mukherjee D and Moliterno DJ. High Dose Tirofiban In Waksman R
and Ajani A (eds) Pharmacology in the Cath Lab, Blackwell Publishing, 2008
65. Mukherjee D and Roffi M. Coronary Artery Disease In Cho L and Griffin B (eds)
The Cardiology Intensive Board Review Question Book (2nd Edition). Philadelphia, PA:
Lippincott Raven, 2008
66. Mukherjee D. Right and Left Heart Catheterization, Myocardial, Valvular, and
Pericardial Disease In ACCSAP 7 [American College of Cardiology]
67. Mukherjee D. Coronary Angiography: Indications, Contraindications, and
Complications In ACCSAP 7 [American College of Cardiology]
68. Mukherjee D. Catheter Selection, Coronary Artery Anatomy and Anomalies,
Physiologic Assessment of Coronary Stenoses, and Intravascular Ultrasound In ACCSAP
7 [American College of Cardiology]
53
69. Roffi M, Mukherjee D and Windecker S. Percutaneous Coronary Intervention,
Coronary Artery Stents In ACCSAP 7 [American College of Cardiology]
70. Dunn S, Macauley T and Mukherjee D. Antiplatelet and Antithrombotic Agents
During Percutaneous Coronary Intervention In ACCSAP 7 [American College of
Cardiology]
71. Pineda G and Mukherjee D. Balloon Angioplasty, Atherectomy, Distal Embolic
Protection Devices, and Total Occlusion Crossing Devices In ACCSAP 7 [American
College of Cardiology]
72. Das P and Mukherjee D. High-Risk Subsets for Percutaneous Coronary
Intervention and Complications In ACCSAP 7 [American College of Cardiology]
73. Roffi M, Mukherjee D and Windecker S. Restenosis and Stent Thrombosis In
ACCSAP 7 [American College of Cardiology]
74. Roffi M and Mukherjee D. Peripheral Arterial Angiography, Carotid Angiography
and Interventions In ACCSAP 7 [American College of Cardiology]
75. Mukherjee D. Training Standards and Proficiency In ACCSAP 7 [American College
of Cardiology]
76. Mukherjee D. Renal Artery Disease In Garcia M (ed) Textbook of Non-Invasive
Cardiovascular Imaging: The Modern Approach to Cardiovascular Diagnosis and
Therapeutic Guidance (1st Edition). Philadelphia, PA: Lippincott Raven, 2009
77. Mukherjee D, Jacobs BS, Hickenbottom S and Eagle KA. Nonatherosclerotic Large
Vessel Disease. In Cho L, Schneck MJ (eds) Cerebrovascular Disease – A cardiac
perspective, Elmsford, NY: Blackwell/Futura, 2009
54
Invited Lectures
Ultrasound mediated enhancement of myocardial uptake of systemically applied growth
factors (Angiogenesis and Direct Myocardial Revascularization National Meeting, 1999)
Therapeutic Angiogenesis and newer modalities of therapy in the treatment of coronary
artery disease (Cleveland Clinic Foundation Internal medicine Grand rounds, July 6,
2000)
Peripheral vascular diseases: Patient presentation, evaluation and current therapy options
(Cleveland Clinic Cardiology Board Review, September 26, 2000)
Carotid Stenting in High-Risk Patients (International Society of Endovascular Therapy,
Miami, Jan 23, 2001)
Update on Carotid Clinical Trials: SAPPHIRE (International Society of Endovascular
Therapy, Miami, Jan 23, 2001)
Newer modalities of therapy in the treatment of Coronary Artery Disease (University of
Michigan cardiology Grand rounds, Feb 12, 2001)
Significant renal artery stenosis requires medical management (9th Annual New Devices
Seminar, June 30 – July 3, Orlando, Florida)
Angiographic Techniques and Anatomy for Cerebrovascular Disease (9th Annual New
Devices Seminar, June 30 – July 3, Orlando, Florida)
COX-2 inhibitors and cardiovascular risk (Cybersession on Heart.org, 22nd Aug 2001)
55
http://dev.cybersessions.com/conference/22aug01/
Carotid Stenting: Techniques & cerebral protection - current and future devices (3rd
Annual Great Lakes Endovascular Symposium, October 20, 2001, Dearborn, Michigan)
Has carotid stenting eclipsed endarterectomy? (3rd Annual Great Lakes Endovascular
Symposium, October 20, 2001, Dearborn, Michigan)
Therapeutic Angiogenesis (53rd Annual Conference of the Cardiological Society of
India, December 6 - 9, 2001, Hyderabad, India)
Coronary Catheterization and Intervention: Why diabetics are different (University of
Michigan, Update in Internal Medicine, May 2-4, 2002)
Diagnosis and Management of Renal and Peripheral Vascular Diseases (Cleveland Clinic
Foundation, Cleveland, Ohio, Cardiology Grand Rounds, May 31, 2002)
Advances in Interventional Cardiology: Drug eluting stents and emboli protection
devices (University of Michigan Cardiovascular Center Nursing Symposium, June 3-4,
2002)
Management of Peripheral Vascular Diseases (Henry Ford Hospital and Vascular
Institute, Detroit, Michigan, Cardiology Grand Rounds, July 24, 2002)
Creating New Paradigms in the Treatment of Acute Coronary Syndromes. (Michigan
State University Primary Care Symposium, August 16th, 2002)
Acute Coronary Syndromes (Congdon Lecture Series, Genesys Medical Center, October
9th, 2002)
Peripheral Vascular Interventions: Current Role of Cardiologists (University of Michigan
56
Cardiology Grand Rounds, December 3rd, 2002)
Peripheral Vascular Interventions: Current Role for Cardiology (The 25th annual
American College of Cardiology conference at Big Sky, Feb 19th 2003, Montana)
Role and Controversies of Antithrombin Therapy in Acute Coronary syndromes (The 4 th
annual Antithrombotic Therapy Symposium at Dearborn, Michigan, March 5th, 2003)
Clinical Impact of Current Acute Coronary Syndrome Studies for the Primary Care
Physician (Primary Care Update, Muskegon, Michigan, March 19th, 2003)
Percutaneous Treatment of PVD (Controversies in Peripheral Vascular Disease, Loyola
University School of Medicine, March 29th, 2003)
Carotid and Renal Artery Stenosis: Endovascular Therapy (Henry Ford Hospital and
Vascular Institute, Detroit, Michigan, Cardiology Grand Rounds, July 29th, 2003)
Peripheral Vascular Disorders (Internal Medicine Grand Rounds, McLaren Regional
Medical Center, Flint, Michigan, September 5th, 2003)
Peripheral Arterial Disease (Primary Care Update, Metropolitan Hospital, Grand Rapids,
Michigan, November 1st, 2003)
Further Management of a Patient Discharged with the Diagnosis “Acute Coronary
Syndrome” (Updates in Primary Care IV – Office cardiology for the Primary care
Physician, November 22nd, 2003)
Peripheral Arterial Disease – Epidemiology, Diagnosis and Management – (State of the
Heart address at the Loyola University Medical center, November 26th, 2003)
Diabetes, Coronary Artery Disease and Revascularization - (University of Michigan
57
Cardiology Grand Rounds, December 9th, 2003)
Risk factors and their modification: Can ischemic events be avoided? – (Peripheral
Arterial Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio)
Pharmacotherapy for global cardiovascular risk reduction and PAD – (Peripheral Arterial
Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio)
Antiplatelet Agent and peripheral arterial disease – (St Mary Mercy Hospital, Livonia,
Michigan, Internal Medicine Grand Rounds 4th February 2004)
Beta-blockers must be used to reduce cardiovascular mortality in diabetics – (Coronary
Artery Disease 2004, February 20th – 22nd, Mumbai, India)
Effective Antiplatelet therapy – (Coronary Artery Disease 2004, February 20 th – 22nd,
Mumbai, India)
Limb Ischemia – (Coronary Artery Disease 2004, February 20th – 22nd, Mumbai, India)
Carotid Stenting – Anatomy (American College of Cardiology Interventional
symposium, 53rd Scientific session of the American College of Cardiology, March 9th,
2004, New Orleans, LA)
Percutaneous Revascularization: Well Beyond the Coronary Arteries (Kentucky Chapter
of the American college of cardiology - What's New in Clinical Cardiology? Exploring
Facts and Fiction, October 9th, 2004, Lexington, Kentucky)
Invited Discussant – REACT Trial (American Heart Association Scientific Sessions,
November 7th, 2004, New Orleans, LA)
Diabetes, Coronary Artery Disease and Revascularization (University of Kentucky
58
Cardiovascular seminar series, January 28th, 2005, Lexington, Kentucky)
Expectation of Trial Design: Cardiovascular Perspective (Cardiovascular Effects of
Selective Cox-2 Inhibition: Is there a Class Effect? International Cox-2 Study group
Meeting, January 28th – 30th, 2005, Washington, DC)
Aortic dissection: Evaluation and Management – (Coronary Artery Disease 2005,
February 10th – 13th, Agra, India)
Pre-op Evaluation of the Non-cardiac Surgery Patient – (Coronary Artery Disease 2005,
February 10th – 13th, Agra, India)
Emboli Protection Devices in PCI – (Coronary Artery Disease 2005, February 10 th – 13th,
Agra, India)
Peripheral Vascular Disease – Pathophysiology, Diagnosis and Management – (Internal
Medicine Grand rounds, University of Kentucky, April 29th 2005)
Peripheral Vascular Disease – Contemporary Management – (Cardiology Grand rounds,
St John Hospital, Michigan, July 27th 2005)
Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, San
Diego, September 12th, 2005)
Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series,
Philadelphia, September 26th, 2005)
Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series,
Atlanta, October 17th, 2005)
Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series,
59
Houston, November 7th, 2005)
Renal Angioplasty only if BP is uncontrolled– (Coronary Artery Disease 2006, January
13th, Mumbai, India)
Aggressive platelet Inhibition is must in Diabetes with CAD (Coronary Artery Disease
2006, January 13th, Mumbai, India)
Angiogenesis and regeneration of heart muscles in management of Heart failure –
(Coronary Artery Disease 2006, January 15th, Mumbai, India)
Interventional treatment of peripheral arterial Disease (Innovations in intervention, 55 th
Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 12th,
2006)
COX-2 Inhibitors and Cardiovascular Risk, Co-Chair (55th Scientific Sessions of the
American College of Cardiology, Atlanta, Georgia, March 13th, 2006)
Tips for Safe and Effective Carotid Stenting, (Meet the Experts @ the 55th Scientific
Sessions of the American College of Cardiology, Atlanta, Georgia, March 13th, 2006)
The Management of Peripheral Arterial Disease (Cardiovascular Medicine and Surgery:
The latest in medications and Techniques, Southern Kentucky AHEC, April 11, 2006)
Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced
Thrombocytopenia (American College of Cardiology Conversation with Experts, April
12, 2006) http://conversations.acc.org/
Reperfusion Strategies in patients with STEMI (Cardiology Grand Rounds, Harper
University Hospital, Detroit, Michigan, April 13th, 2006)
60
Management of patients with STEMI: Applying the ACC/AHA Guidelines (Cardiology
Grand Rounds, Rosalind Franklin University of Medicine, Chicago, Illinois, May 24 th,
2006)
STEMI Management: An Emergency Department Perspective (Internal Medicine Grand
Rounds, CGH Medical Center, Sterling, Illinois, June 7th, 2006)
Interventional Treatment of Peripheral Arterial Disease. (Appalachian Regional
Healthcare, Medical Staff Update, Whitesburg, Kentucky, June 13, 2006)
Management of patients with STEMI: Applying the ACC/AHA Guidelines (Internal
Medicine Grand Rounds, Norman Regional Hospital, Oklahoma City, Oklahoma, June
15th, 2006)
Carotid Artery Stenting. (International College of Surgeons, 68th Annual Surgical
Update, Nashville, Tennessee, June 23rd, 2006)
Cardiology Update (University of Kentucky Internal Medicine Grand Rounds, August
11th, 2006)
Interventional Treatment of Peripheral Arterial Disease. (Boyle County Medical Society,
Danville, Kentucky, August 15th, 2006)
STEMI Management: An Emergency Department Perspective (Internal Medicine Grand
Rounds, Blessing Hospital, Quincy, Illinois, August 16th, 2006)
Reperfusion Strategies in patients with STEMI (Cardiology Grand Rounds, Good
Samaritan Hospital, Dayton, Ohio, August 23rd, 2006)
Non ST segment elevation myocardial infarction: Concept Diagnosis and Treatment.
(Med Congress – International Medical Congress, Shanghai, China, September 17th,
61
2006)
Chronic Total occlusion of a coronary artery and percutaneous coronary intervention.
(Med Congress – International Medical Congress, Shanghai, China, September 17th,
2006)
Aspirin and Clopidogrel resistance in ACS – Is it relevant in Clinical Practice? (Coronary
Artery Disease 2006, September 29th, Mumbai, India)
IIb/IIIa inhibitor in ACS patients – US Perspective (Coronary Artery Disease
Symposium 2006, September 30th, Mumbai, India)
Are IIb/IIIa inhibitors replaced in ACS (Coronary Artery Disease 2006, September 30 th,
Mumbai, India)
Diabetes and CAD – Preventing Progression of Atherosclerosis is the real challenge
(Coronary Artery Disease 2006, October 1st, Mumbai, India)
Treatment of In-Stent Restenosis by a Paclitaxel Coated Balloon Catheter -
PACCOCATH ISR II Trial-Discussant (American Heart Association, November 13th,
2006, Chicago, IL)
Management of patients with STEMI: Applying the ACC/AHA Guidelines (Internal
Medicine Grand Rounds, Medical Center of Independence, Independence, Missouri,
November 9th, 2006)
Management of patients with STEMI: Applying the ACC/AHA Guidelines (Internal
Medicine Grand Rounds, Erlanger Medical Center, Chattanooga, Tennessee, November
30th, 2006)
Management of patients with STEMI: Applying the ACC/AHA Guidelines (Internal
62
Medicine Grand Rounds, Saint Mary’s Hospital, Streator, Illinois, December 19th, 2006)
Peripheral Vascular Disease – Epidemiology, Clinical Features and Management
(Internal Medicine Noon Conference, University of Kentucky, Lexington, Kentucky,
January 4th, 2007)
Managing STEMI: Timing and Decision making in the Emergency Department (Medical
Grand Rounds, Shawnee Mission Medical Center, Shawnee Mission, Kansas, January
16th, 2007)
Management of Peripheral Arterial Disease (Meeting the Challenges to improve
Cardiovascular Outcomes, Southern Kentucky AHEC, Corbin, KY, February 22, 2007)
Vertebral Artery Intervention (American College of Cardiology/i2 Symposium, 56th
Annual Scientific Sessions, New Orleans, Louisiana, March 25, 2007)
Pitfalls in Vascular Ultrasound (Meet the Experts, American College of Cardiology, 56th
Annual Scientific Sessions, New Orleans, Louisiana, March 26, 2007)
Beta-Blockers, Clonidine and Calcium-Channel Blockers Perioperatively - Perioperative
Evaluation of the Cardiac Patient (Meet the Experts, American College of Cardiology,
56th Annual Scientific Sessions, New Orleans, Louisiana, March 27, 2007)
Nonsteroidal Anti-Inflammatory Drugs and the Heart: What Is the Danger? (Meet the
Experts, American College of Cardiology, 56th Annual Scientific Sessions, New Orleans,
Louisiana, March 27, 2007)
Reperfusion Strategies in patients with STEMI (Internal Medicine Grand Rounds, Poplar
Bluff Regional Medical Center, Poplar Bluff, Missouri, April, 20th, 2007)
Combination Secondary Preventive Therapies for Cardiovascular Diseases (How to
63
decrease the odds of developing cardiovascular disease, 16th Annual AHEC Summer
conference, Mt Vernon, June 21, 2007)
Prophylaxis and Management of DVT. Mega Annual Conference of Saviors – Critical
Care Conference, Phuket, Thailand, August 16th, 2007
Emergency management of Acute Coronary syndromes. Mega Annual Conference of
Saviors – Critical Care Conference, Phuket, Thailand, August 16th, 2007
Renal Insufficiency – The Hidden Risk (Coronary Artery Disease 2007, October 5th,
Mumbai, India)
Clinical Risk Scores in ACS (Coronary Artery Disease 2007, October 5th, Mumbai,
India)
Clopidogrel and Stent Thrombosis (Coronary Artery Disease 2007, October 5th, Mumbai,
India)
Managing STEMI in hospitals without PCI (Internal Medicine Grand Rounds, Claremore
Indian Hospital, Claremore, Oklahoma, October 12th, 2007)
Management of patients with STEMI: Applying the ACC/AHA Guidelines (CME
Distinguished Lecture Series, ARH Regional Medical Center, Hazard, Kentucky,
December 5th, 2007)
Pre-Hospital and Emergency Department Management of STEMI (Medical Grand
Rounds, Delta Regional Medical center, Greenville, Mississippi, December 6th, 2007)
How to improve quality in PCI (The 30th annual American College of Cardiology
conference at Big Sky, Feb 21st 2008, Montana)
Drug eluting stents – The truth (The 30th annual American College of Cardiology
64
conference at Big Sky, Feb 22nd 2008, Montana)
An Update on Coronary Artery Disease in the South Asian population. (Annual
Scientific Sessions of the American Association of Cardiologists of Indian origin, March
30th, 2008, Chicago, IL)
Aortic Dissection and Acute Aortic Syndromes (Cardiology Grand Rounds, Medical
College of Wisconsin, Milwaukee, June 3rd, 2008)
65